Insufficient scRNA-seq data for expression of CHKB at single-cell level.
Insufficient scRNA-seq data for expression of CHKB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 4822.21 | 89 / 89 | 22% | 0.34 | 199 / 901 |
lung | 100% | 4703.64 | 578 / 578 | 18% | 0.25 | 203 / 1155 |
esophagus | 100% | 3547.69 | 1445 / 1445 | 17% | 0.24 | 31 / 183 |
bladder | 100% | 3901.76 | 21 / 21 | 15% | 0.22 | 75 / 504 |
intestine | 100% | 4168.60 | 966 / 966 | 14% | 0.20 | 73 / 527 |
pancreas | 100% | 2121.32 | 328 / 328 | 13% | 0.18 | 24 / 178 |
thymus | 100% | 6880.14 | 653 / 653 | 12% | 0.17 | 75 / 605 |
brain | 98% | 2325.31 | 2598 / 2642 | 13% | 0.18 | 95 / 705 |
uterus | 100% | 3871.01 | 170 / 170 | 10% | 0.13 | 45 / 459 |
stomach | 100% | 3144.85 | 359 / 359 | 9% | 0.12 | 25 / 286 |
skin | 100% | 2628.30 | 1806 / 1809 | 8% | 0.10 | 37 / 472 |
breast | 100% | 4616.13 | 459 / 459 | 7% | 0.10 | 75 / 1118 |
adrenal gland | 100% | 4522.86 | 258 / 258 | 7% | 0.09 | 15 / 230 |
prostate | 100% | 5779.75 | 245 / 245 | 5% | 0.06 | 23 / 502 |
ovary | 100% | 2941.23 | 180 / 180 | 4% | 0.06 | 19 / 430 |
liver | 100% | 2351.92 | 226 / 226 | 3% | 0.04 | 12 / 406 |
adipose | 100% | 4044.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 8684.14 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 2490.06 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2717.70 | 1329 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3207.96 | 918 / 929 | 0% | 0 | 0 / 0 |
muscle | 93% | 1316.30 | 744 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.21 | 4 / 29 |
eye | 0% | 0 | 0 / 0 | 5% | 0.06 | 4 / 80 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.05 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006657 | Biological process | CDP-choline pathway |
GO_0007517 | Biological process | muscle organ development |
GO_0006646 | Biological process | phosphatidylethanolamine biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004103 | Molecular function | choline kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0004305 | Molecular function | ethanolamine kinase activity |
Gene name | CHKB |
Protein name | Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB) |
Synonyms | CHKL CHETK |
Description | FUNCTION: Has a key role in phospholipid metabolism, and catalyzes the first step of phosphatidylethanolamine and phosphatidylcholine biosynthesis. . |
Accessions | ENST00000406938.3 [Q9Y259-1] Q9Y259 |